Home » Healthcare » Pharmaceuticals » Bovine Respiratory Disease Treatment Market

Bovine Respiratory Disease Treatment Market By Treatment (Vaccines, Antibiotics, Immunomodulators), By Disease, By Distribution Cannel – Growth, Future Prospects And Competitive Analysis 2017 – 2025.

Published: | Report ID: 3441 | Report Format : PDF

The purpose of this research study titled “Bovine Respiratory Disease Treatment Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” is to provide investors, developers, company executives, and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global bovine respiratory disease treatment market. This report presents and analyses the major trends prevalent in the global market for bovine respiratory disease treatment, as well as the market’s size and forecast.

This report categorizes the global bovine respiratory disease treatment market in terms of treatment type, disease type, distribution channel, and geographical distribution. Based on treatment types, the global bovine respiratory disease treatment market is categorized into vaccines, antibiotics, immunomodulators, and others. Pneumonia, upper respiratory tract infections, and diphtheria are the major disease types considered when bovine respiratory drugs are administered. In terms of distribution channels, this market is categorized into hospitals, clinics, research institutions, and others. The market size and forecast for each mentioned segment for the period 2015–2025 are presented in the report, along with respective CAGRs for the forecast duration of 2017–2025.

Geographically, the global bovine respiratory disease treatment market is best understood by segmenting it into five major regions and five major region-level markets, as follows:

  • North America
  • U.S.
  • Canada
  • Europe
  • EU 7
  • CIS
  • Rest of Europe
  • Asia-Pacific
  • China
  • India
  • Asia-Pacific region
  • Latin America
  • Brazil
  • Mexico
  • rest of Latin America
  • Middle East and Africa
  • GCC
  • Rest of the Middle East and Africa

This study presents the market size and forecast for each considered geographical market for the period 2015-2025, as well as CAGRs for the forecast period 2017-2025, and is further cross-sectional presented in terms of disease type, treatment type, distribution channel, and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global bovine respiratory disease treatment market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with a profile of key market players currently enjoying prominent positions in the industrial rubber goods market. The key players profiled in this report are Bayer AG, Boehringer Ingelheim GmbH, Bimeda, Ceva, Elanco, Merck & Co., Inc., Merial, Virbac Group, Vetoquinol, and Zoetis Services LLC.

The global bovine respiratory disease treatment market is studied for the following segments:

  • Treatment Type
  • Vaccine
  • Antibiotics
  • Immunomodulators
  • Others
  • Disease Type
  • Pneumonia
  • Upper Respiratory Tract Infections
  • Diphtheria
  • Distribution Channel
  • Hospitals
  • Clinics
  • Research Institutions
  • Others

Vaccines form the largest treatment type for bovine respiratory treatment. Cattle farms have the highest demand for drugs to treat bovine respiratory disease. In such a form of animal husbandry, disease prevention has a critical status for ensuring overall cattle health and, consequently, operational output. Among the disease types, upper respiratory tract infections have the largest prevalence in cattle. Because of the high prevalence of such infections, the demand for drugs for upper respiratory tract infections is highest in emerging markets such as Latin America and Asia Pacific. Hospitals form the largest distribution channel for bovine respiratory disease drugs. Local farmers and breeders often enter into long-term alliances with veterinary hospitals to meet their periodic needs for vaccination and regular check-ups of their cattle. Clinics, on the other hand, have a considerable yet rapidly progressing status in the market. The proliferation of drug administration from clinics is observed to be highest in regions where the veterinary healthcare system is not yet fully established Geographically, the global bovine respiratory diseases treatment market is cumulative for North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America.

Among the considered regional markets, North America currently dominates the global bovine respiratory disease treatment market, followed by Europe. The maturity of the veterinary healthcare market in North America and Western Europe significantly contributes to the dominance of these regions. Other factors contributing to the success of the North American and European markets are the existence of a well-structured animal husbandry industry and the ready availability of the most advanced veterinary healthcare services and drugs. The Asia Pacific market is anticipated to progress at the fastest growth rate during the forecast period. The growth of the Asia Pacific market is majorly attributed to the rapidly increasing demand for animal protein foods and processed meat, the substantial proliferation of animal husbandry businesses, and the evolution of veterinary healthcare infrastructure in the region. Market players have also intensified their efforts toward increasing their footprints in untapped emerging markets in order to gain profitability and maintain a competitive edge.

The detailed regional classification of the global bovine respiratory disease treatment market is as follows:

  • North America (U.S. and Canada)
  • Europe (EU 7, CIS, and Other European Countries)
  • Asia-Pacific (China, India, and the Rest of Asia-Pacific)
  • Middle East and Africa (GCC plus the rest of the Middle East and Africa)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Bovine Respiratory Disease Treatment Market Portraiture
2.1.1. Global Bovine Respiratory Disease Treatment Market, by Treatment Type, 2016
2.1.2. Global Bovine Respiratory Disease Treatment Market, by Disease Type, 2016
2.1.3. Global Bovine Respiratory Disease Treatment Market, by Distribution Channel, 2016
2.1.4. Global Bovine Respiratory Disease Treatment Market, by Geography, 2016

Chapter 3. Bovine Respiratory Disease Treatment: Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.4.1. Attractive Investment Proposition, by Geography
3.5. Competitive Landscape
3.5.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Bovine Respiratory Disease Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Vaccines
4.3. Antibiotics
4.4. Immunomodulators
4.5. Others

Chapter 5. Global Bovine Respiratory Disease Treatment Market, by Disease Type, 2015 – 2025 (US$ Mn)
5.1. Overview
5.2. Pneumonia
5.3. Upper Respiratory Tract Infections
5.4. Diphtheria

Chapter 6. Global Bovine Respiratory Disease Treatment Market, by Distribution Cannel, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. Hospitals
6.3. Clinics
6.4. Research Institutions
6.5. Others

Chapter 7. Global Bovine Respiratory Disease Treatment Market, by Geography, 2015 – 2025
7.1. Overview
7.2. North America Bovine Respiratory Disease Treatment Market Analysis, 2015 – 2025
7.2.1. North America Bovine Respiratory Disease Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
7.2.2. North America Bovine Respiratory Disease Treatment Market, by Disease Type, 2015 – 2025 (US$ Mn)
7.2.3. North America Bovine Respiratory Disease Treatment Market, by Distribution Channel, 2015 – 2025 (US$ Mn)
7.2.4. North America Bovine Respiratory Disease Treatment Market, By Country, 2015 – 2025 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe Bovine Respiratory Disease Treatment Market Analysis, 2015 – 2025
7.3.1. Europe Bovine Respiratory Disease Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
7.3.2. Europe Bovine Respiratory Disease Treatment Market, by Disease Type, 2015 – 2025 (US$ Mn)
7.3.3. Europe Bovine Respiratory Disease Treatment Market, by Distribution Channel, 2015 – 2025 (US$ Mn)
7.3.4. Europe Bovine Respiratory Disease Treatment Market, by Region, 2015 – 2025 (US$ Mn)
7.3.4.1. E.U.7
7.3.4.2. CIS
7.3.4.3. Rest of Europe
7.4. Asia Pacific Bovine Respiratory Disease Treatment Market Analysis , 2015 – 2025
7.4.1. Asia Pacific Bovine Respiratory Disease Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
7.4.2. Asia Pacific Bovine Respiratory Disease Treatment Market, by Disease Type, 2015 – 2025 (US$ Mn)
7.4.3. Asia Pacific Bovine Respiratory Disease Treatment Market, by Distribution Channel, 2015 – 2025 (US$ Mn)
7.4.4. Asia Pacific Bovine Respiratory Disease Treatment Market, BY Country, 2015 – 2025 (US$ Mn)
7.4.4.1. China
7.4.4.2. India
7.4.4.3. Rest of APAC
7.5. Latin America Bovine Respiratory Disease Treatment Market Analysis , 2015 – 2025
7.5.1. Latin America Bovine Respiratory Disease Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
7.5.2. Latin America Bovine Respiratory Disease Treatment Market, by Disease Type, 2015 – 2025 (US$ Mn)
7.5.3. Latin America Bovine Respiratory Disease Treatment Market, by Distribution Channel, 2015 – 2025 (US$ Mn)
7.5.4. Latin America Bovine Respiratory Disease Treatment Market, by Country, 2015 – 2025 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa (MEA) Bovine Respiratory Disease Treatment Market Analysis, 2015 – 2025
7.6.1. MEA Bovine Respiratory Disease Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
7.6.2. MEA Bovine Respiratory Disease Treatment Market, by Disease Type, 2015 – 2025 (US$ Mn)
7.6.3. MEA Bovine Respiratory Disease Treatment Market, by Distribution Channel, 2015 – 2025 (US$ Mn)
7.6.4. MEA Bovine Respiratory Disease Treatment Products Market, by Region, 2015 – 2025 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA

Chapter 8. Company Profiles
8.1. Bayer AG
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Boehringer Ingelheim GmbH
8.3. Bimeda
8.4. Ceva
8.5. Elanco
8.6. Merck & Co., Inc.
8.7. Merial
8.8. Virbac Group
8.9. Vetoquinol
8.10. Zoetis Services LLC
8.11. Other Notable Players

List Of Tables :

TABLE 1 Global Bovine Respiratory Disease Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 2 Global Bovine Respiratory Disease Treatment Market, by Disease Type, 2015 – 2025 (US$ Mn)
TABLE 3 Global Bovine Respiratory Disease Treatment Market, by Distribution Channel, 2015 – 2025 (US$ Mn)
TABLE 4 North America Bovine Respiratory Disease Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 5 North America Bovine Respiratory Disease Treatment Market, by Disease Type, 2015 – 2025 (US$ Mn)
TABLE 6 North America Bovine Respiratory Disease Treatment Market, by Distribution Channel, 2015 – 2025 (US$ Mn)
TABLE 7 North America Bovine Respiratory Disease Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 8 Europe Bovine Respiratory Disease Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 9 Europe Bovine Respiratory Disease Treatment Market, by Disease Type, 2015 – 2025 (US$ Mn)
TABLE 10 Europe Bovine Respiratory Disease Treatment Market, by Distribution Channel, 2015 – 2025 (US$ Mn)
TABLE 11 Europe Bovine Respiratory Disease Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 12 Asia Pacific Bovine Respiratory Disease Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 13 Asia Pacific Bovine Respiratory Disease Treatment Market, by Disease Type, 2015 – 2025 (US$ Mn)
TABLE 14 Asia Pacific Bovine Respiratory Disease Treatment Market, by Distribution Channel, 2015 – 2025 (US$ Mn)
TABLE 15 Asia Pacific Bovine Respiratory Disease Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 16 Latin America Bovine Respiratory Disease Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 17 Latin America Bovine Respiratory Disease Treatment Market, by Disease Type, 2015 – 2025 (US$ Mn)
TABLE 18 Latin America Bovine Respiratory Disease Treatment Market, by Distribution Channel, 2015 – 2025 (US$ Mn)
TABLE 19 Latin America Bovine Respiratory Disease Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 20 Middle East and Africa Bovine Respiratory Disease Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 21 Middle East and Africa Bovine Respiratory Disease Treatment Market, by Disease Type, 2015 – 2025 (US$ Mn)
TABLE 22 Middle East and Africa Bovine Respiratory Disease Treatment Market, by Distribution Channel, 2015 – 2025 (US$ Mn)
TABLE 23 Middle East and Africa Bovine Respiratory Disease Treatment Market, by Country, 2015 – 2025 (US$ Mn)

List Of Figures :

FIG. 1 Bovine Respiratory Disease Treatment: Market Segmentation
FIG. 2 Global Bovine Respiratory Disease Treatment Market, by Treatment Type, 2016 (US$ Mn)
FIG. 3 Global Bovine Respiratory Disease Treatment Market, by Disease Type, 2016 (US$ Mn)
FIG. 4 Global Bovine Respiratory Disease Treatment Market, by Distribution Channel, 2016 (US$ Mn)
FIG. 5 Global Bovine Respiratory Disease Treatment Market, by Geography, 2016 (Value %)
FIG. 6 Attractive Investment Proposition, by Geography
FIG. 7 Market Competition Landscape, by Key Players, 2016
FIG. 8 Global Bovine Respiratory Vaccines Market, 2015 – 2025 (US$ Mn)
FIG. 9 Global Bovine Respiratory Antibiotics Market, 2015 – 2025 (US$ Mn)
FIG. 10 Global Bovine Respiratory Immunomodulators Market, 2015 – 2025 (US$ Mn)
FIG. 11 Global Other Bovine Respiratory Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 12 Global Bovine Pneumonia Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 13 Global Bovine Upper Respiratory Infections Drugs Market 2015 – 2025 (US$ Mn)
FIG. 14 Global Bovine Diphtheria Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 15 Global Bovine Respiratory Treatment Drugs Market in Hospitals, 2015 – 2025 (US$ Mn)
FIG. 16 Global Bovine Respiratory Disease Treatment Drugs Market in Clinics, 2015 – 2025 (US$ Mn)
FIG. 17 Global Bovine Respiratory Disease Treatment Drugs Market in Research Institutions, 2015 – 2025 (US$ Mn)
FIG. 18 Global Bovine Respiratory Disease Treatment Drugs Market in Other Distribution Channels, 2015 – 2025 (US$ Mn)

Frequently Asked Questions

What is the size of Bovine Respiratory Disease Treatment Market?

The market for Bovine Respiratory Disease Treatment Market is expected to reach XX Mn in 2025.

What is the Bovine Respiratory Disease Treatment Market CAGR?

The Bovine Respiratory Disease Treatment Market is expected to see significant CAGR growth over the coming years, at XX%.

What is the Forecast period considered for Bovine Respiratory Disease Treatment Market?

The report is forecasted to 2017-2025.

What is the base year considered for Bovine Respiratory Disease Treatment Market?

The base year of this report is 2016.

Who are the major players in this Market?

Bayer AG,Boehringer Ingelheim GmbH,Bimeda,Ceva,Elanco are some of the major players in the global market.

Prostate Cancer Market

Published:
Report ID: 36273

Antineoplastic Agents Market

Published:
Report ID: 36065

US Retail Pharmacy Market

Published:
Report ID: 32801

OTC Vitamins Dietary Supplements Market

Published:
Report ID: 35994

Liposomes Market

Published:
Report ID: 35888

UK Iron Supplement Market

Published:
Report ID: 35709

U.S. Iron Supplement Market

Published:
Report ID: 35688

Malignant Ascites Market

Published:
Report ID: 11184

Middle East and Africa In-Vitro Fertilization (IVF) Market

Published:
Report ID: 35578

Chronic Myeloid Leukemia (CML) Treatment Market

Published:
Report ID: 2939

Combination Therapies In Aesthetics Market

Published:
Report ID: 35434

CAR T-Cell Therapy Market

Published:
Report ID: 2051

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN